series-b
Stage
2018
Founded
2
Investors
About
Pheon Therapeutics is a biotechnology company specializing in the development of Antibody-Drug Conjugates (ADCs) for treating hard-to-treat cancers, including solid tumors and liquid cancers resistant to other treatments.
Explore Pheon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.